Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: A review of spontaneous reports

CMAJ. Canadian Medical Association Journal

Volumn 155, Issue 5, 1996, Pages 519-527

  Liu, Barbara A ^a   Mittmann, Nicole ^a,b   Knowles, Sandra R ^a   Shear, Neil H ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DRUG INDUSTRY; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; DRUG USE; FEMALE; HUMAN; HYPERNATREMIA; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RESEARCH; RISK;

EID: 0029843155     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Bartter FC. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Dis Mon 1973;20:3-46.
2. Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 1967;42:790-806.
3. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
4. Hwang AS, Magraw RM. Syndrome of inappropriate secretion of antidiuretic hormone due to fluoxetine [letter]. Am J Psychiatry 1989;146:399.
5. Cohen BJ, Mahelsky M, Adler L. More cases of SIADH with fluoxetine [letter]. Am J Psychiatry 1990;147:948-9.
6. Commans JH, Edwards RA. Fluoxetine and hyponatraemia [letter]. N Z Med J 1990;103:106.
7. Marik PE, van Heerden W, Steenkamp V. Fluoxetine-induced syndrome of inappropriate antidiuretic hormone excretion [letter]. S Afr Med J 1990;78:760-1.
8. Staab JP, Yerkes SA, Cheney EM, Clayton AH. Transient SIADH associated with fluoxetine [letter]. Am J Psychiatry 1990;147:1569-70.
9. Vishwanath BM, Navalgund AA, Cusano W, Navalgund KA. Fluoxetine as a cause of SIADH [letter]. Am J Psychiatry 1991;148:542-3.
10. Blacksten JV, Birt JA. Syndrome of inappropriate secretion of antidiuretic hormone secondary to fluoxetine. Ann Pharmacother 1993;27:723-4.
11. Kazal LA, Hall DL, Miller LG, Noel ML. Fluoxetine-induced SIADH: A geriatric occurrence? J Fam Pract 1993; 36:341-3.
12. Ball CJ, Herzberg J. Hyponatraemia and selective serotonin reuptake inhibitors. Int J Geriatr Psychiatry 1994;9:819-22.
13. Pillans PI, Coulter DM. Fluoxetine and hyponatraemia - a potential hazard in the elderly. N Z Med J 1994;107:85-6.
14. Druckcnbrod R, Mulsant BH. Fluoxetine-induced syndrome of inappropriate antidiuretic hormone secretion: a geriatric case report and a review of the literature. J Geriatr Psychiatry Neurol 1994;7:255-8.
15. Jackson C, Carson W, Markowitz J, Mintzer J. SIADH associated with fluoxetine and sertraline therapy [letter]. Am J Psychiatry 1995;152:809-8.
16. McHardy KC. Syndrome of inappropriate antidiuretic hormone secretion due to fluvoxamine therapy. Br J Clin Pharmacol 1993;47:62-3.
17. Goddard C, Paton C. Hyponatraemia associated with paroxetine [letter]. BMJ 1992;305:1332.
18. Chua TP, Vong SK. Hyponatraemia associated with paroxetine [letter]. BMJ 1993;306:143.
19. Crews JR, Potts NLS, Schreiber J, Lipper S. Hyponatremia in a patient treated with sertraline [letter]. Am J Psychiatry 1993;150:1564
20. Doshi D, Borison R. Association of transient SIADH with sertraline [letter]. Am J Psychiatry 1994;151:779-80.
21. Llorente MD, Gorelick M, Silverman MA. Sertraline as the cause ot inappropriate antidiuretic hormone sercretion [letter]. J Clin Psychiatry 1994;55:543-4.
22. Thornton SL, Resch DS. SIADH associated with sertraline therapy [letter]. Am J Psychiatry 1995;152:809.
23. Lindeman RD, Van Buren HC, Raisz LG. Osmolar concentrating ability in healthy young men and hospitalized patients without renal disease. N Engl J Med 1960;262:1306-14.
24. Miller M. Fluid and electrolyte balance in the elderly. Geriatrics 1987;42:65-76.
25. Helderman JH, Vestal RE, Rowe JW, Tobin JD, Andres R, Robertson GL. The response of arginine vasopressin to intravenous ethanol and hypertonic saline in man: the impact of aging. J Gerontol 1978;33:39-47.
26. Seidl Lg, Thornton GF, Cluff LE. Epidemiological studies of adverse drug reactions. Am J Public Health 1965;55:1170-5.
27. Hurwitz N. Predisposing factors in adverse reactions to drugs. BMJ 1969;1:536-8.
28. Caranasos GH, Steart RB, Cluff LE. Drug-induced illness leading to hospitalization. JAMA 1974;227:713-7.
29. Blazer D, Hughers DC, George LK. The epidemiology of depression in an elderly community population. Gerontologist 1987;27:281-7.
30. Franks P, Clancy CM, Naumburg EH. Sex, access, and excess. Ann Intern Med 1995;123:548-50.
31. Verbrugge LM, Steiner RP. Physician treatment of men and women patients: Sex bias or appropriate care? Med Care 1981;19:609-32.
32. Weitzel WD, Shraberg D, Work J. Inappropriate ADH secretion: the role of drug re-challenge. Psychosomatic 1980; 21:771-9.
33. Ledingham JGG. Water and sodium homeostasis. In: Weatherall DJ, Ledingham JGG, Warrell DA, editors: Oxford Textbook of Medicine, vol 2. Oxford, England: Oxford University Press, 1987:18-29
34. Spigset O, Hedenmalm K. Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs. Drug Safety 1995;12:209-25.
35. Cunningham ET Jr, Sawchenk PE. Reflex control of magnocellular vasopressin and oxytocin secretion. Trends Neurosci 1991;14:406-11.
36. Yamaguchi K, Hama H. Facilatory role of central dopamine in the osmotic release of vasopresin. Brain Res 1989;481:388-91.
37. Yamaguchi K, Hama H, Adachi C. Inhibitory role of periventricular dopaminergic mechanisms in hemorrhage-induced vasopressin secretion in conscious rats. Brain Res 1990;513:335-8.
38. Verghese C, de Leon H, Simpson GM. Neuroendocrine factors influencing polydipsia in psychiatric patients: an hypothesis. Neuropsychopharmacology 1993;9:157-66.
39. Leibowitz SF, Jhanwar-Uniyal M, Dvorkin B, et al. Distribution of α-adrenergic and dopaminergic receptors in discrete hypothalamic areas of rat. Brain Res 1982;233:97-114.
40. Leibowitz SF, Eidelman D, Suh JS, et al. Mapping study of noradrenergic stimulation of vasopressin release. Exp Neurol 1990;110:298-305.
41. Anderson IK, Martin GR, Ramage AG. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats. Br J Pharmacol 1992;107: 1020-8.
42. Brownfield MS, Greathouse H, Lorens SA, Armstrong H, Urban JH, Van de Kar LD. Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats. Neuroendocrinology 1988;47:277-83.
43. Grebb JB. Serotonin-specific reuptake inhibitors: introduction and overview. In: Kaplan HI, Sadock BJ, editors. Comprehensive Textbook of Psychiatry. vol 2. 6th ed. Baltimore: Williams and Wilkins, 1995:2054-6.
44. Bressier R, Katz MD. Drug therapy for geriatric depression. Drugs Aging 1993;3:195-219.
45. Crewe JK, Lennard MS, Tucker GT, Woods FR, Haddock RE. The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. Br J Clin Pharmacol 1992;347:262-5.
46. Vogt CL. Adverse drug reactions: getting information back from MEDWATCH [letter]. JAMA 1994;272:590.
47. Taylor IC, McConnell JG. Severe hyponatraemia associated with selective serotonin reuptake inhibitors. Scot Med J 1995;40:147-8.
48. Bluff DD, Oji N. SIADH in a patient receiving sertraline [letter]. Ann Intern Med 1995;123:811.
49. Leung M, Remick R: Sertraline-associated hyponatremia [letter]. Can J Psychiatry 1995;40:497-8.
50. Ayonrinde OT, Teutens SG, Sanfilippo FM. Paroxetine-induced SIADH [letter]. Med J Aust 1995;163:390.